Bridging Funding Australia Why Approved Medicines Take 466 Days to Reach Patients By Steve|2026-01-28T20:36:17+10:00January 28th, 2026|Categories: All, Patient Access & System Response|Tags: bridging funding, patient access, PBS access| Read More 0
ATM Mutation in Cancer: Context Before Conclusions By Steve|2026-01-28T14:07:40+10:00January 28th, 2026|Categories: All, Understanding Cancer Biology|Tags: ATM, BRCA1, BRCA2, MMR| Read More 0
HER2 Biliary Cancer: ERBB2 & Enhertu Explained By Steve|2025-11-07T10:26:40+10:00September 26th, 2025|Categories: All|Tags: Enhertu, ERBB2, HER2, Podcast| Read More 0
Cholangiocarcinoma Australia Webinar Review 2025 By Steve|2025-08-10T12:48:31+10:00August 10th, 2025|Categories: All|Tags: Analytical, Cholangio Breakdown, Cholangio Today, Clinicians, Precision Oncology, Researchers| Read More 0
FGFR2 Fusion The Fourth Domino By Steve|2025-06-30T06:55:24+10:00June 28th, 2025|Categories: All, Cholangio Today, Understanding Cancer Biology| Read More 0
Beth’s Cholangio Story By Claire|2025-07-11T11:44:19+10:00June 27th, 2025|Categories: All, Patient Story| Read More 1
FGFR2 Mutation Drives Cholangiocarcinoma By Steve|2025-06-29T17:18:51+10:00June 9th, 2025|Categories: All, Cholangio Today, Understanding Cancer Biology|Tags: FGFR2 fusion, Fusion Mutation| Read More 0
Pemazyre – The FGFR2 Circuit Breaker By Steve|2025-06-09T11:46:42+10:00June 6th, 2025|Categories: All, Treatments & Trials|Tags: FGFR2 fusion, FGFR2 inhibitor, Fusion Mutation, iCCA, inhibitor, Pemazyre, Pemigatinib, targeted therapy| Read More 1
Sandra Robertson cholangiocarcinoma survivor By Steve|2025-06-09T12:05:00+10:00June 1st, 2025|Categories: All, Patient Story|Tags: 5 years, Patient Survivor, Sandra Robertson| Read More 0
Dr Chris Rogan at APSCVIR – Through The Cholangio Lens By Steve|2025-09-05T11:49:28+10:00May 29th, 2025|Categories: All, Cholangio Today, Clinicians, SURGERY, Treatments & Trials| Read More 0